Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 5Completed 5Active not recruiting 4Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 54INDUSTRY 21NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 7Magnetic Resonance Spectroscopy 6Radiotherapy 5Biopsy 4Radiation 3Cytarabine 3Cyclophosphamide 3venetoclax 2Vincristine 2Standard of Care 2Spinal Puncture 2Practice Guidelines as Topic 2High-Energy Shock Waves 2Daunorubicin 2Azacitidine 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1sulforaphane 1sacituzumab govitecan 1revumenib 1prednylidene 1pertuzumab 1pembrolizumab 1pegaspargase 1nelarabine 1merphos 1liposomal doxorubicin 1lenvatinib 1gilteritinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × pembrolizumab × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡